FRONTIER GROUP HOLDINGS INC (ULCC)

US35909R1086 - Common Stock

6.22  -1.05 (-14.44%)

After market: 6.2 -0.02 (-0.32%)

Fundamental Rating

2

Taking everything into account, ULCC scores 2 out of 10 in our fundamental rating. ULCC was compared to 24 industry peers in the Passenger Airlines industry. ULCC has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ULCC is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

ULCC had negative earnings in the past year.
ULCC had a negative operating cash flow in the past year.
ULCC had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ULCC reported negative operating cash flow in multiple years.

1.2 Ratios

ULCC has a Return On Assets (-1.12%) which is in line with its industry peers.
ULCC has a Return On Equity (-12.31%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.12%
ROE -12.31%
ROIC N/A
ROA(3y)-1.15%
ROA(5y)-0.66%
ROE(3y)-9.56%
ROE(5y)-10.99%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ULCC has a Gross Margin (52.21%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ULCC has declined.
ULCC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.74%
GM growth 5Y-2.37%

2

2. Health

2.1 Basic Checks

ULCC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ULCC has been increased compared to 1 year ago.
ULCC has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.63, we must say that ULCC is in the distress zone and has some risk of bankruptcy.
ULCC has a Altman-Z score of 0.63. This is in the lower half of the industry: ULCC underperforms 62.50% of its industry peers.
ULCC has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
ULCC has a Debt to Equity ratio of 0.36. This is amongst the best in the industry. ULCC outperforms 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 0.63
ROIC/WACCN/A
WACC8.24%

2.3 Liquidity

ULCC has a Current Ratio of 0.52. This is a bad value and indicates that ULCC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ULCC (0.52) is worse than 70.83% of its industry peers.
ULCC has a Quick Ratio of 0.52. This is a bad value and indicates that ULCC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.52, ULCC is doing worse than 62.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52

4

3. Growth

3.1 Past

The earnings per share for ULCC have decreased strongly by -115.52% in the last year.
The Revenue has decreased by -0.41% in the past year.
The Revenue has been growing by 10.73% on average over the past years. This is quite good.
EPS 1Y (TTM)-115.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.84%
Revenue 1Y (TTM)-0.41%
Revenue growth 3Y42.13%
Revenue growth 5Y10.73%
Sales Q2Q%0.62%

3.2 Future

Based on estimates for the next years, ULCC will show a very strong growth in Earnings Per Share. The EPS will grow by 112.01% on average per year.
Based on estimates for the next years, ULCC will show a quite strong growth in Revenue. The Revenue will grow by 11.28% on average per year.
EPS Next Y-140.7%
EPS Next 2Y133.55%
EPS Next 3Y112.01%
EPS Next 5YN/A
Revenue Next Year4.28%
Revenue Next 2Y9.45%
Revenue Next 3Y11.28%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ULCC. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 10.37, which indicates a very decent valuation of ULCC.
ULCC's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of ULCC to the average of the S&P500 Index (22.57), we can say ULCC is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.37

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ULCC's earnings are expected to grow with 112.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y133.55%
EPS Next 3Y112.01%

0

5. Dividend

5.1 Amount

ULCC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FRONTIER GROUP HOLDINGS INC

NASDAQ:ULCC (10/29/2024, 8:00:01 PM)

After market: 6.2 -0.02 (-0.32%)

6.22

-1.05 (-14.44%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.40B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.37
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.12%
ROE -12.31%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 52.21%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-115.52%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-140.7%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-0.41%
Revenue growth 3Y42.13%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y